https://squawknews.com/news/930030-strategy-s-michael-saylor-proposes-10b-30b-digital-credit-plan 2026-11-14T17:19:43.164Z https://squawknews.com/news/930029-novo-s-wegovy-pill-helps-patients-lose-about-6-of-weight-in-three-months 2026-11-14T17:15:34.783Z https://squawknews.com/news/930027-novo-s-wegovy-pill-linked-to-6-2-average-weight-loss-over-three-months 2026-11-14T17:15:11.339Z https://squawknews.com/news/930026-novo-wegovy-pill-users-lose-about-6-of-weight-in-three-months-data-show 2026-11-14T17:15:01.175Z https://squawknews.com/news/930018-lilly-says-obesity-drugs-helped-patients-lose-weight-in-clinical-trials 2026-11-14T17:01:21.997Z https://squawknews.com/news/930017-lilly-reports-weight-loss-in-obesity-drug-clinical-trials 2026-11-14T17:01:11.653Z https://squawknews.com/news/930014-eli-lilly-says-eloratzp-lowered-a1c-by-up-to-2-9 2026-11-14T17:01:07.272Z https://squawknews.com/news/930011-eli-lilly-says-eloratzp-lowered-a1c-by-up-to-2-9 2026-11-14T17:01:02.633Z https://squawknews.com/news/930010-lilly-phase-3-trial-reports-average-21-4-bmi-reduction-with-zepbound 2026-11-14T17:01:02.567Z https://squawknews.com/news/930009-lilly-phase-2-data-show-eloratzp-weight-loss-of-up-to-54-1-pounds 2026-11-14T17:01:07.497Z